CHA Biotech Co. Ltd (085660) - Net Assets

Latest as of December 2025: ₩809.25 Billion KRW ≈ $548.42 Million USD

Based on the latest financial reports, CHA Biotech Co. Ltd (085660) has net assets worth ₩809.25 Billion KRW (≈ $548.42 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩2.55 Trillion ≈ $1.73 Billion USD) and total liabilities (₩1.74 Trillion ≈ $1.18 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 085660 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩809.25 Billion
% of Total Assets	31.77%
Annual Growth Rate	14.3%
5-Year Change	77.45%
10-Year Change	182.64%
Growth Volatility	59.1

CHA Biotech Co. Ltd - Net Assets Trend (2008–2025)

This chart illustrates how CHA Biotech Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 085660 asset base for the complete picture of this company's asset base.

Annual Net Assets for CHA Biotech Co. Ltd (2008–2025)

The table below shows the annual net assets of CHA Biotech Co. Ltd from 2008 to 2025. For live valuation and market cap data, see CHA Biotech Co. Ltd market capitalisation.

Year	Net Assets	Change
2025-12-31	₩809.25 Billion ≈ $548.42 Million	+184.26%
2024-12-31	₩284.69 Billion ≈ $192.93 Million	-56.62%
2023-12-31	₩656.33 Billion ≈ $444.79 Million	+124.98%
2022-12-31	₩291.73 Billion ≈ $197.70 Million	-36.03%
2021-12-31	₩456.06 Billion ≈ $309.06 Million	+28.43%
2020-12-31	₩355.09 Billion ≈ $240.64 Million	-5.86%
2019-12-31	₩377.18 Billion ≈ $255.61 Million	+15.35%
2018-12-31	₩326.99 Billion ≈ $221.60 Million	+41.71%
2017-12-31	₩230.74 Billion ≈ $156.37 Million	-19.41%
2016-12-31	₩286.32 Billion ≈ $194.04 Million	-1.30%
2015-12-31	₩290.10 Billion ≈ $196.60 Million	-33.68%
2014-12-31	₩437.45 Billion ≈ $296.46 Million	-14.62%
2013-12-31	₩512.34 Billion ≈ $347.21 Million	+54.59%
2012-12-31	₩331.41 Billion ≈ $224.59 Million	+16.10%
2011-12-31	₩285.46 Billion ≈ $193.45 Million	+80.40%
2010-12-31	₩158.24 Billion ≈ $107.24 Million	+25.98%
2009-12-31	₩125.61 Billion ≈ $85.12 Million	+50.59%
2008-12-31	₩83.41 Billion ≈ $56.52 Million	--

Equity Component Analysis

This analysis shows how different components contribute to CHA Biotech Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 27340.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩164.80 Billion	54.10%
Other Components	₩139.81 Billion	45.90%
Total Equity	₩304.61 Billion	100.00%

CHA Biotech Co. Ltd Competitors by Market Cap

The table below lists competitors of CHA Biotech Co. Ltd ranked by their market capitalization.

Company	Market Cap
TeamViewer AG F:TMV	$885.29 Million
CureVac NV F:5CV	$885.32 Million
O-Bank Co Ltd TW:2897	$885.38 Million
Sichuan Jinshi Technology Co Ltd Class A SHE:002951	$885.41 Million
V V Food & Beverage Co Ltd SHG:600300	$885.03 Million
CW Enerji SA IS:CWENE	$884.89 Million
China Petrochemical Development Corp TW:1314	$884.79 Million
Shanghai Kaibao Pharmaceutical SHE:300039	$884.70 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in CHA Biotech Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 284,688,978,290 to 304,608,524,760, a change of 19,919,546,470 (7.0%).
Net loss of 109,876,117,780 reduced equity.
New share issuances of 181,730,635,060 increased equity.
Other factors decreased equity by 51,934,970,810.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩-109.88 Billion	-36.07%
Share Issuances	₩181.73 Billion	+59.66%
Other Changes	₩-51.93 Billion	-17.05%
Total Change	₩-	7.00%

Book Value vs Market Value Analysis

This analysis compares CHA Biotech Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 4.29x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 2.95x to 4.29x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩5784.92	₩17090.00	x
2017-12-31	₩4599.52	₩17090.00	x
2018-12-31	₩6231.05	₩17090.00	x
2019-12-31	₩7187.10	₩17090.00	x
2020-12-31	₩6757.39	₩17090.00	x
2021-12-31	₩8106.14	₩17090.00	x
2022-12-31	₩5184.66	₩17090.00	x
2023-12-31	₩4996.00	₩17090.00	x
2024-12-31	₩4695.25	₩17090.00	x
2025-12-31	₩3985.66	₩17090.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently CHA Biotech Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -36.07%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -8.66%
• Asset Turnover: 0.50x
• Equity Multiplier: 8.36x
Recent ROE (-36.07%) is below the historical average (-2.02%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	5.35%	6.26%	0.69x	1.25x	₩-3.88 Billion
2009	4.37%	1.51%	1.57x	1.83x	₩-7.02 Billion
2010	3.23%	1.34%	1.14x	2.11x	₩-10.72 Billion
2011	1.41%	1.19%	0.71x	1.67x	₩-24.43 Billion
2012	7.94%	5.30%	0.89x	1.68x	₩-6.33 Billion
2013	6.63%	4.82%	0.77x	1.79x	₩-12.93 Billion
2014	0.96%	0.83%	0.56x	2.09x	₩-26.87 Billion
2015	-5.16%	-3.80%	0.61x	2.22x	₩-43.97 Billion
2016	5.90%	3.76%	0.58x	2.69x	₩-11.75 Billion
2017	-20.15%	-11.14%	0.53x	3.44x	₩-69.58 Billion
2018	7.46%	4.99%	0.52x	2.90x	₩-8.31 Billion
2019	12.29%	8.67%	0.46x	3.08x	₩8.66 Billion
2020	-5.25%	-2.81%	0.51x	3.70x	₩-54.17 Billion
2021	-3.06%	-1.92%	0.47x	3.37x	₩-59.57 Billion
2022	-16.30%	-5.63%	0.53x	5.51x	₩-76.72 Billion
2023	-3.00%	-0.88%	0.55x	6.13x	₩-36.57 Billion
2024	-2.83%	-0.77%	0.48x	7.71x	₩-36.52 Billion
2025	-36.07%	-8.66%	0.50x	8.36x	₩-140.34 Billion

Industry Comparison

This section compares CHA Biotech Co. Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $368,573,438,392
Average return on equity (ROE) among peers: 0.96%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
CHA Biotech Co. Ltd (085660)	₩809.25 Billion	5.35%	2.15x	$885.14 Million
ORIENTBIO Inc. (002630)	$57.60 Billion	0.00%	0.70x	$43.15 Million
Green Cross (005250)	$1.51 Trillion	0.20%	0.84x	$425.10 Million
Green Cross Holdings Preference Shares (005257)	$1.85 Trillion	1.30%	0.98x	$3.74 Million
Pharmicell (005690)	$51.52 Billion	8.44%	0.23x	$736.42 Million
GeneOne Life Science Inc (011000)	$39.74 Billion	0.00%	0.49x	$49.94 Million
HLB Co. Ltd (028300)	$19.44 Billion	0.00%	0.66x	$5.41 Billion
Daesung Microbiological Labs. Co. Ltd (036480)	$37.00 Billion	2.34%	0.69x	$19.29 Million
Seoulin Bioscience Co.Ltd (038070)	$51.49 Billion	4.00%	0.38x	$37.92 Million
Hyundai Bioscience Co. Ltd (048410)	$58.24 Billion	3.27%	0.77x	$872.13 Million
iNtRON Biotechnology Inc (048530)	$11.93 Billion	-9.93%	0.65x	$77.34 Million

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$885.14 Million

₩1.31 Trillion KRW

Market Cap Rank

#9659 Global

#275 in Korea

Share Price

₩17090.00

Change (1 day)

-1.78%

52-Week Range

₩9870.00 - ₩23850.00

All Time High

₩40950.00